Design, synthesis, and biological evaluation of substituted naphthalene imides and diimides as anticancer agent∞

Journal of Medicinal Chemistry

Volumn 52, Issue 23, 2009, Pages 7873-7877

  Tumiatti, Vincenzo ^a   Milelli, Andrea ^a   Minarini, Anna ^a   Micco, Marialuisa ^a   Campani, Anna Gasperi ^a,b   Roncuzzi, Laura ^a,c   Baiocchi, Daniela ^a   Marinello, Jessica ^a   Capranico, Giovanni ^a   Zini, Maddalena ^a   Stefanelli, Claudio ^a   Melchiorre, Carlo ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CASPASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITONAFIDE; NAPHTHALENE DERIVATIVE; PROTEIN KINASE B; PROTEIN P53;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; DRUG CYTOTOXICITY; DRUG DESIGN; DRUG DNA INTERACTION; DRUG SCREENING; DRUG SYNTHESIS; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; ENZYME REGULATION; HUMAN; HUMAN CELL; MOLECULAR MECHANICS; SURVIVAL;

ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL PROLIFERATION; DNA; DNA TOPOISOMERASES; DRUG DESIGN; HUMANS; IMIDES; NAPHTHALENES;

EID: 72249110438     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm901131m     Document Type: Article

References (28)

1. Chabner, B. A.; Roberts, T. G., Jr. Timeline: chemotherapy and the war on cancer. Nat. Rev. Cancer 2005, 5, 65-72.
2. Martinez, R.; Chacon-Garcia, L. The search of DNA-intercalators as antitumoral drugs: what it worked and what did not work. Curr. Med. Chem. 2005, 12, 127-151.
3. Persil, O.; Hud, N. V. Harnessing DNA intercalation. Trends Biotechnol. 2007, 25, 433-436.
4. Ferguson, L. R.; Denny, W. A. Genotoxicity of non-covalent interactions: DNA intercalators. Mutat. Res. 2007, 623, 14-23.
5. Schneider, H. J. Ligand binding to nucleic acids and proteins: Does selectivity increase with strength? Eur. J. Med. Chem. 2008, 43, 2307-2315.
6. Strekowski, L.; Wilson, B. Noncovalent interactions withDNA: an overview. Mutat. Res. 2007, 623, 3-13.
7. Yen, S. F.; Gabbay, E. J.; Wilson, W. D. Interaction of aromatic imides with deoxyribonucleic acid. Spectrophotometric and viscometric studies. Biochemistry 1982, 21, 2070-2076.
8. Brana, M. F.; Ramos, A. Naphthalimides as anti-cancer agents: synthesis and biological activity. Curr. Med. Chem.: Anti-Cancer Agents 2001, 1, 237-255.
9. Liu, Z. R.; Hecker, K. H.; Rill, R. L. Selective DNA binding of (N-alkylamine)-substituted naphthalene imides and diimides to G+C-rich DNA. J. Biomol. Struct. Dyn. 1996, 14, 331-339.
10. Ingrassia, L.; Lefranc, F.; Kiss, R.; Mijatovic, T. Naphthalimides and azonafides as promising anti-cancer agents. Curr. Med. Chem. 2009, 16, 1192-1213.
11. Diaz-Rubio, E.; Martin, M.; Lopez-Vega, J. M.; Casado, A.; Benavides, A. Phase I study of mitonafide with a 3-day administration schedule: early interruption due to severe central nervous system toxicity. Invest. New Drugs 1994, 12, 277-281.
12. Ratain, M. J.; Mick, R.; Berezin, F.; Janisch, L.; Schilsky, R. L.; Williams, S. F.; Smiddy, J. Paradoxical relationship between acetylator phenotype and amonafide toxicity. Clin. Pharmacol. Ther. 1991, 50, 573-579.
13. Zhu, H.; Huang, M.; Yang, F.; Chen, Y.; Miao, Z. H.; Qian, X. H.; Xu, Y. F.; Qin, Y. X.; Luo, H. B.; Shen, X.; Geng, M. Y.; Cai, Y. J.; Ding, J. R16, a novel amonafide analogue, induces apoptosis and G2-M arrest via poisoning topoisomerase II. Mol. Cancer Ther. 2007, 6, 484-495.
14. Van Quaquebeke, E.; Mahieu, T.; Dumont, P.; Dewelle, J.; Ribaucour, F.; Simon, G.; Sauvage, S.; Gaussin, J. F.; Tuti, J.; El Yazidi, M.; Van Vynckt, F.; Mijatovic, T.; Lefranc, F.; Darro, F.; Kiss, R. 2,2,2-Trichloro-N-({2-[2- (dimethylamino)ethyl]-1,3-dioxo- 2,3-dihydro-1H-benzo[de]isoquinolin- 5-yl}carbamoyl)acetamide (UNBS3157), a novel nonhematotoxic naphthalimide derivative with potent antitumor activity. J. Med. Chem. 2007, 50, 4122-4134.
15. Mijatovic, T.; Mahieu, T.; De Neve, N.; Dewelle, J.; Simon, G.; Dehoux, M. J. M.; van der Aar, E.; Haibe-Kains, B.; Bontempi, G.; Deacestecker, C.; Van Quaquebeke, E.; Darro, F.; Kiss, R. UNBS5162, a novel naphthalimide that decreases CXCL chemokine expression in experimental prostate cancers. Neoplasia 2008, 10, 573-586. (Pubitemid 351770301)
16. Tumiatti, V.; Rosini, M.; Bartolini, M.; Cavalli, A.; Marucci, G.; Andrisano, V.; Angeli, P.; Banzi, R.; Minarini, A.; Recanatini, M.; Melchiorre, C. Structure-activity relationships of acetylcholinesterase noncovalent inhibitors based on a polyamine backbone. 2. Role of the substituents on the phenyl ring and nitrogen atoms of caproctamine. J. Med. Chem. 2003, 46, 954-966.
17. Licchelli, M.; Linati, L.; Orbelli Biroli, A.; Perani, E.; Poggi, A.; Sacchi, D. Metal-induced assembling/disassembling of fluorescent naphthalenediimide derivatives signalled by excimer emission. Chemistry 2002, 8, 5161-5169. (Pubitemid 35398287)
18. Morgan, A. R.; Lee, J. S.; Pulleyblank, D. E.; Murray, N. L.; Evans, D. H. Review: ethidium fluorescence assays. Part 1. Physicochemical studies. Nucleic Acids Res. 1979, 7, 547-569.
19. McConnaughie, A. W.; Jenkins, T. C. Novel acridine-triazenes as prototype combilexins: synthesis, DNA binding, and biological activity. J. Med. Chem. 1995, 38, 3488-3501.
20. De Isabella, P.; Zunino, F.; Capranico, G. Base sequence determinants of amonafide stimulation of topoisomerase II DNA cleavage. Nucleic Acids Res. 1995, 23, 223-229.
21. Wang, J.; Wu, A.; Xu, Y.; Liu, J.; Qian, X. M(2)-A induces apoptosis and G(2)-M arrest via inhibiting PI3K/Akt pathway in HL60 cells. Cancer Lett. 2009, 283, 193-202.
22. Lavrik, I. N.; Golks, A.; Krammer, P. H. Caspases: pharmacological manipulation of cell death. J. Clin. Invest. 2005, 115, 2665-2672.
23. Cross, T. G.; Scheel-Toellner, D.; Henriquez, N. V.; Deacon, E.; Salmon, M.; Lord, J. M. Serine/threonine protein kinases and apoptosis. Exp. Cell Res. 2000, 256, 34-41.
24. Lakin, N. D.; Jackson, S. P. Regulation of p53 in response toDNA damage. Oncogene 1999, 18, 7644-7655.
25. Vogelstein, B.; Lane, D.; Levine, A. J. Surfing the p53 network. Nature 2000, 408, 307-310.
26. Manning, B. D.; Cantley, L. C. AKT/PKB signaling: navigating downstream. Cell 2007, 129, 1261-1274.
27. Shaul, Y. D.; Seger, R. The MEK/ERK cascade: from signaling specificity to diverse functions. Biochim. Biophys. Acta 2007, 1773, 1213-1226.
28. Balmanno, K.; Cook, S. J. Tumour cell survival signalling by the ERK1/2 pathway. Cell Death Differ. 2009, 16, 368-377.